Effie Webb at Business Insider covered our recent funding round and showcased our pitch deck.
"Sam Windsor thinks some failed drugs deserve a second chance and his startup, Ignota Labs, is betting AI can turn that into a moneymaker.
Instead of starting from scratch, the startup acquires abandoned drug candidates, diagnoses their safety problems using AI, and modifies compounds for another attempt at clinical trials.
'Traditional drug discovery might cost over $10 million and take seven to eight years just to reach clinical trials,' Windsor, who is the startup's CEO, told Business Insider. 'Our approach can achieve the same in less than two years and for under $1 million.'"
Read more:
‘This startup is using AI to give failed drugs a second chance,’ can be read in full at Business Insider.
Published: 24 March 2025 by Business Insider.
